103 related articles for article (PubMed ID: 5305356)
1. [Clinical significance of the use of antifibrinolytic agents].
Czuczor H; Vecsey D; Bánkuti P
Orv Hetil; 1969 Apr; 110(17):966-9. PubMed ID: 5305356
[No Abstract] [Full Text] [Related]
2. [On the use of antifibrinolytic agents in urology].
Rosdy E; Biró J; Szendröi Z; Szabó V
Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
[No Abstract] [Full Text] [Related]
3. Indications for antifibrinolytic therapy.
Prentice CR
Thromb Diath Haemorrh; 1975 Dec; 34(3):634-43. PubMed ID: 1108280
[No Abstract] [Full Text] [Related]
4. [Hemostatic effect of "coagumin" in clinical use].
Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
Hinyokika Kiyo; 1966 Jun; 12(6):576-82. PubMed ID: 6006918
[No Abstract] [Full Text] [Related]
5. The effects of trasylol and aminocaproic acid in post-prostatectomy haemorrhage.
Pearson BS
Br J Urol; 1969 Oct; 41(5):602. PubMed ID: 5309948
[No Abstract] [Full Text] [Related]
6. Trasylol therapy of haemorrhage in surgical patients.
Amris CJ
Acta Chir Scand Suppl; 1967; 378():45-52. PubMed ID: 5300106
[No Abstract] [Full Text] [Related]
7. [Surgical complications caused by fibrinolysis and their treatment following prostate surgery].
Wölfer E; Mihalecz K; Karátson A; Nagy I
Z Urol Nephrol; 1967 Dec; 60(12):853-7. PubMed ID: 4174722
[No Abstract] [Full Text] [Related]
8. [Coagulation physiological bases of antifibrinolytic treatment in prostatectomies].
Neef H; Preusser KP; Anger G; Richter M
Zentralbl Chir; 1967 Apr; 92(13):486-90. PubMed ID: 5591468
[No Abstract] [Full Text] [Related]
9. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.
Nilsson IM; Andersson L; Björkman SE
Acta Med Scand Suppl; 1966; 448():1-46. PubMed ID: 5221699
[No Abstract] [Full Text] [Related]
10. [The use of antifibrinolytic drugs (epsilon-amino caproic acid and Trasylol) in prostatic surgery].
Carbone G; Di Grazia G
Arch Ital Urol; 1966 Nov; 39(1):3-16. PubMed ID: 4172061
[No Abstract] [Full Text] [Related]
11. [Acute fibrinolysis after prostatectomy].
Aiello D
Sicil Sanit; 1966; 3(1):24-9. PubMed ID: 5296527
[No Abstract] [Full Text] [Related]
12. [Antifibrinolytic therapy in obstetrics and gynecology].
Schild W
Gynaecologia; 1965; 160(1):39-48. PubMed ID: 5294537
[No Abstract] [Full Text] [Related]
13. [Epsilon-aminocaproic acid and trasylol as hemostyptic agents in prostatic surgery].
Schmutzler R; Fürstenberg H
Helv Chir Acta; 1966 Aug; 33(4):478-83. PubMed ID: 5300406
[No Abstract] [Full Text] [Related]
14. [Treatment of hematuria in hemorrhagic diathesis by means of epsilon-aminocaproic acid with concomitant determination of urokinase].
Cohen I; Djaldetti M; Gorshein D; de Vries A
Folia Clin Int (Barc); 1965 Nov; 15(11):537-8. PubMed ID: 5867570
[No Abstract] [Full Text] [Related]
15. Control of bleeding during and after prostatectomy.
Fam A
Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
[No Abstract] [Full Text] [Related]
16. [The use of epsilon-aminocaproic acid in urology].
Oberst O
Z Urol Nephrol; 1965; 58(10):717-25. PubMed ID: 5866679
[No Abstract] [Full Text] [Related]
17. [Essential hematuria and its treatment with fibrinolysis inhibitors].
Zhila VV
Vrach Delo; 1968 Feb; 2():82-5. PubMed ID: 5669369
[No Abstract] [Full Text] [Related]
18. [Fibrinolytic bleedings in urology].
Lipsky H; Hubmer O
Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
[No Abstract] [Full Text] [Related]
19. Amicar and hyperfibrinolysis.
Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
[No Abstract] [Full Text] [Related]
20. [On local treatment of hemorrhages following prostatectomy with antifibrinolytic agents].
Vecsey D; Bánkuti P; Czuczor H
Z Urol Nephrol; 1967 Dec; 60(12):831-5. PubMed ID: 5302248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
